News | Cardiovascular Surgery | March 31, 2016

Minimally Invasive Mitral Valve Surgery Viable Option for Select Heart Patients

First multi-institutional study shows mini-MVR patients experienced shorter hospital stays, fewer blood transfusions

minimally invasive mitral valve repair, mini-MVR, comparison study, conventional surgery, University of Virginia

March 31, 2016 — Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery, according to an article posted online by The Annals of Thoracic Surgery. Mini-MVR patients also experience shorter hospital stays and fewer blood transfusions.

MVR is a common treatment for mitral valve disease, including mitral stenosis (when the valve doesn’t allow enough blood flow) and mitral regurgitation (when blood leaks backwards out of the valve).

“Our research is the first multi-institutional study of patients undergoing mini-MVR as compared to traditional surgery,” said Emily A. Downs, M.D., from the University of Virginia in Charlottesville, who led the study. “We believe our results are important as they may facilitate further adoption of mini-MVR and provide patients with more options when faced with surgery.”

Downs, Gorav Ailawadi, M.D., and researchers from a statewide consortium of 18 hospitals in the Virginia Cardiac Surgery Quality Initiative examined records for 1,304 patients who underwent isolated MVR from 2011 to 2014. This included 425 (32.6 percent) who underwent mini-MVR.

During traditional MVR, a cardiothoracic surgeon makes a 6- to 8-inch-long incision down the center of the sternum (breastbone) to open the chest and provide direct access to the heart. In mini-MVR, the surgeon makes a 2- to 3-inch incision between the ribs on the right chest.

The researchers found that patients undergoing mini-MVR had similar rates of mortality, stroke (in contrast to previous research) and other complications compared with conventional MVR. They also found that mini-MVR patients experienced shorter intensive care unit and hospital lengths of stay, as well as fewer blood transfusions. Total hospital costs were similar between the two groups, despite previous assumptions by the researchers that mini-MVR might lead to higher costs.

“In our experience, mini-MVR is suitable for many patients and is particularly useful in both elderly patients with mobility issues and in young, healthy patients who desire quicker recovery and return to work,” said Ailawadi. “Patients who are not ideal candidates for mini-MVR include those with severe mitral annular calcification, right ventricular dysfunction or considerable aortic calcification.”

Adoption of mini-MVR has been slow; however, procedural volume is expected to increase as more results on outcomes and costs become available.

“Mini-MVR may not be appropriate for all centers, surgeons or patients; however, it should be an essential approach to consider in the armamentarium of an advanced mitral valve center,” said Ailawadi.

For more information: www.annalsthoracicsurgery.org

Related Content

Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Edwards Intuity Elite sutureless aortic valve, first implants in Connecticut, WCHN, Western Connecticut Health Network
News | Cardiovascular Surgery | February 16, 2017
Western Connecticut Health Network (WCHN) cardiothoracic surgeons Cary Passik, M.D., and Robert Gallagher, M.D., were...
Overlay Init